Fycompa (Perampanel)

Fycompa contains active pharmaceutical ingredient Perampanel. It is a non-competitive AMPA glutamate receptor antagonist used as adjunctive therapy to treat Partial-Onset Seizures with or without secondarily generalized seizures in patients with epilepsy aged 12 years and older, and Primary Generalized Tonic-Clonic (PGTC) Seizures in patients with epilepsy aged 12 years and older

Recommended Dosage: 

Dosage for Partial-Onset Seizures: The recommended starting dosage is 2 mg once a day taken orally at bedtime. The dosage of Fycompa tablets can be increased by increments of 2 mg once a day no more often than at weekly intervals. The maintenance dose range is 8 to 12 mg once daily in the absence of enzyme-inducing antiepileptic drugs, although some individuals may respond with 4 mg daily dose. A dose of 12 mg once a day resulted in somewhat higher reductions in the rates of seizure than 8 mg once daily dose but with a substantial increase in side effects. Adjust individual dosing on behalf of clinical response as well as tolerability.

Dosage for Primary Generalized Tonic-Clonic Seizures: The recommended starting dosage is 2 mg once a day taken orally at bedtime. The dosage of Fycompa can be increased by increments of 2 mg once daily no more often than at weekly intervals. In individuals not using enzyme-inducing antiepileptic drugs, the maintenance dose is 8 mg once daily taken at bedtime. Those who are tolerating Fycompa 8 mg once a day and need further reduction of seizures may consider a dose increase up to 12 mg once daily in case tolerated. Adjust individual dosing on behalf of clinical response as well as tolerability.

• Perampanel may increase the probability of psychiatric events. Monitor patients during therapy and for at least 30 days after the final dose, mainly when taking higher doses and during the initial few weeks of treatment or at other times of dose increases. Reduce the dose in case these symptoms occur. Permanently discontinue treatment for persistent severe or worsening signs or behavior of psychiatric and refer for psychiatric evaluation.
• Antiepileptic drugs, including Fycompa 2 mg/4 mg/6 mg/8 mg/10 mg/12 mg may increase the probability of suicidal thoughts/behavior in those taking these medications. Those treated with any antiepileptic drugs should be evaluated for the occurrence or worsening of suicidal thoughts or behavior, depression, or any other unusual changes in mood/behavior.
• Perampanel can be responsible for causing somnolence and fatigue-associated events (including asthenia, fatigue, and lethargy). Respective patients should avoid engaging in any hazardous activity that requires mental alertness, such as operating dangerous machinery or motor vehicles until the effect of medicine is known. 
• There is a probability of increased seizure frequency in individuals with seizure disorders when antiepileptic drugs (AEDs) are withdrawn abruptly. A gradual withdrawal is recommended for antiepileptic drugs, but in case of withdrawal is a response to side effects, quick withdrawal can be considered.

What documents are required to import FYCOMPA® to India?

FYCOMPA® (perampanel) tablets can be imported by patients or government hospitals on the name of the patients only. 

The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patients ID proof (issued by the government of India)

How does the order be confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from Doctor
• Import permit if applicable

Send your enquiry to find,

• FYCOMPA in South East Asia – China (Beijing, Shanghai, Chongqing, Tianjin and Shenzhen), Indonesia, Cambodia, Malaysia, the Philippines, Thailand, Singapore, Vietnam, Hong Kong.
• FYCOMPA in the United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
• FYCOMPA in North America – Mexico.
• FYCOMPA in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
• FYCOMPA in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
• FYCOMPA in Russia CIS – Kazakhstan, Armenia, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
• FYCOMPA in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
• FYCOMPA in Australia and New Zealand.

Is FYCOMPA® available in India?

FYCOMPA® (perampanel tablets) is a (prescription medicine, prescription medication, or prescription drug) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability of FYCOMPA® in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
• Medicine Price.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

FYCOMPA® can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of FYCOMPA® (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for FYCOMPA® price in India. 

We take to guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network is able to source the FYCOMPA® (Cancer Treatment Medicines) from across the globe and has the ability to supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Fycompa®?

Perampanel is a Generic Name for the trade name drug Fycompa®.

What is the Manufacturer’s Name of Fycompa®?

Fycompa® is manufactured by Eisai Inc.

Is Fycompa® approved by the FDA?

Yes, Fycompa® is approved by the FDA. Date of first/initial approval: October 22, 2012.

What is the dosage and form of Fycompa® supplied?

Fycompa® is supplied as Tablets: 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, 12 mg, and Oral Suspension: 0.5 mg/mL for oral administration. 

What are the most common side effects of Fycompa®? 

The most common side effects of Fycompa® are fatigue, dizziness, falls, somnolence, irritability, nausea, headache, weight gain, contusion, vertigo, ataxia, vomiting, anxiety, and abdominal pain.

How much does Fycompa® cost in India?

The medicine Fycompa cost in India can vary. In order to procure this epilepsy/seizure medicine legally, you can Call or WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

What are the storage conditions of Fycompa®?

Store tablets at 20 to 25°C (68 to 77°F); excursions permitted to 15 to 30°C (59 to 86°F). Do not store Oral Suspension beyond 30°C (86°F). Avoid freezing it. Use within 90 days after the first opening of the bottle.

Is it safe to buy Fycompa® online in India?

Yes, one can buy Fycompa online in India at the lowest price from the Indian Pharma Network (IPN) if the medication Fycompa® is not (yet) registered or is unavailable in your country. We can help facilitate the supply of Fycompa® tablets through legal channels.